The DOI matches its Crossref record; 89 of the 91 references it cites were found in a registry or an index.
Rodent models for Alzheimer’s disease drug discovery
Open accessAbstract
INTRODUCTION: Alzheimer's disease (AD) is a neurodegenerative disorder characterized by memory loss and personality changes, leading to dementia. Histopathological hallmarks are represented by aggregates of beta-amyloid peptide (Aβ) in senile plaques and deposition of hyperphosphorylated tau protein in neurofibrillary tangles in the brain. Rare forms of early onset familial Alzheimer's disease are due to gene mutations. This has prompted researchers to develop genetically modified animals that could recapitulate the main features of the disease. The use of these models is complemented by non-genetically modified animals. AREAS COVERED: This review summarizes the characteristics of the most used transgenic (Tg) and non-Tg models of AD. The authors have focused on models mainly used in their laboratories including amyloid precursor protein (APP) Tg2576, APP/presenilin 1, 3xAD, single h-Tau, non-Tg mice treated with acute injections of Aβ or tau, and models of physiological aging. EXPERT OPINION: Animal models of disease might be very useful for studying the pathophysiology of the disease and for testing new therapeutics in preclinical studies but they do not reproduce the entire clinical features of human AD. When selecting a model, researchers should consider the various factors that might influence the phenotype. They should also consider the timing of testing/treating animals since the age at which each model develops certain aspects of the AD pathology varies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Meanwhile, being entirely derived from human cells, these organoids can fully replicate human biology and potentially reduce the translational barriers from experimental findings to therapeutic applications (20–22), offering advantages over animal models (23–25).”
From Understanding monocyte-driven neuroinflammation in Alzheimer’s disease using human cortical organoid microphysiological systems (2025) · cites this paper as [23]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126
Oakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1202-06.2006 · Cited by 3,530 · cited 1×
“Neuronal loss, potentially due to intraneuronal Ab accumulation [59], has been found in a 5XTg mouse model containing APP (Swedish K670N/M671L, Florida I716V, and London V717I) and PSEN1 (M146L and L286V) mutations.”
BackgroundAlzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516
Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1
Duff, K., Eckman, C., Zehr, C., Yu, X., Prada, C.-M., Pérez‐Tur, J., Hutton, M., Buée, L., Harigaya, Y., Yager, D., et al. (1996) · Nature · doi:10.1038/383710a0 · Cited by 1,486
Borchelt, D. R., Thinakaran, G., Eckman, C. B., Lee, M. K., Davenport, F., Ratovitsky, T., Prada, C.-M., Kim, G., Seekins, S., Yager, D., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80230-5 · Cited by 1,478
Holcomb, L., Gordon, M. N., McGowan, E., Yu, X., Benkovic, S., Jantzen, P., Wright, K., Saad, I., Mueller, R., Morgan, D., et al. (1998) · Nature Medicine · doi:10.1038/nm0198-097 · Cited by 1,386
Billings, L. M., Oddo, S., Green, K. N., McGaugh, J. L., & LaFerla, F. M. (2005) · Neuron · doi:10.1016/j.neuron.2005.01.040 · Cited by 1,294
Research works printed but not linked: 5
- Alzheimer A, 1906, Neurol Centralblatt, 23, 1129
- 10.1037/0735-7044.113.5.982 · DOI
- Li H, 2015, Neurobiol Aging
- Moe JG, 2008, Evaluation of the effect of extracellular tau oligomers on synaptic function
- Moe JG, 2010, Validation of extracellular tau oligomer target for drug discovery in a novel animal model
Cited by
Sorted by citations
Items 201–219 of 219
Grigoletti-Lima, G. B. (2020) · doi:10.47749/t/unicamp.2020.1167784
First-generation animal models of Aβ amyoloidosis: Pros and cons of the overexpression paradigm
Saido, T. C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-28979-8.00012-7
Mukhina, K. A., Mitkevich, V. A., & Popova, I. Y. (2024) · Acta Naturae · doi:10.32607/actanaturae.27439
Rutten, K. (2024) · Springer eBooks · doi:10.1007/978-3-031-61992-2_10
Immunotherapy for Alzheimer's disease: advances in adaptive immunity
Zhi, T. (2025) · New discovery. · doi:10.61958/ndfs3904
Translational research and the implementation process
Schoenherr, J. R. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-90509-1.00021-7
Inokenteva, V., Gruden, M. A., Solovieva, O. A., Mikhailova, N. P., Ratmirov, A. M., & Storozheva, Z. I. (2025) · Journal Biomed · doi:10.33647/2074-5982-21-4-96-100
Motor deficits in the McGill-R-Thy1-APP transgenic rat model of Alzheimer’s disease
Roddick, K. M., Northrup, P., Schellinck, H. M., & Brown, R. E. (2026) · Behavioural Processes · doi:10.1016/j.beproc.2026.105341 · Cited by 1
Giménez‐Llort, L., Vida, C., Félix, J., Quer-Palomas, S., Manassra, R., & la Fuente, M. D. (2026) · Diseases · doi:10.3390/diseases14020061
Han, B., Chen, Y., Ouyang, W., Chen, D., Li, J., Liang, W., Zhang, X., Wei, C., Liu, L., Yan, S., et al. (2026) · Scientific Data · doi:10.1038/s41597-026-06882-4
Bergeron, S. (2018) · theses.fr (ABES) · doi:10.70675/36a54739zd120z440bzac6aze1ff3180f9f1
Optimizing grid preparation methods for TEM imaging of amyloid-forming proteins
Chellali, R., Tan, S., & Khemtémourian, L. (2026) · Biophysical Chemistry · doi:10.1016/j.bpc.2026.107676
Wang, Y., Qin, S., Gong, X., Bai, H., Li, S., Cai, H., Hu, Y., Zhao, Y., Bai, M., Song, C., et al. (2026) · Brain Research · doi:10.1016/j.brainres.2026.150474
Xing, S., Ren, P., Chen, Z., & Fu, Y. (2026) · Neuroscience · doi:10.1016/j.neuroscience.2026.07.063
Li, X., Liu, X., Xinran, S. O. N. G., Zhou, Y., Yang, D., Wang, Y., Mao, S., Rang, X., Hong, X., Wang, X., et al. (2026) · BioMed Research International · doi:10.1155/bmri/8975137
Surhan, A., Oad, J., Kumar, B., Memon, S. N., Essrani, C., Muhammad, F., Kashif, S. N., Abbas, S. M. I., Ameen, T. B., Sauleh, A., et al. (2026) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-026-01263-5
Weng, L., Chen, X., Xie, X., Liu, L., Yu, D., Zou, Q., Zhao, J., & Hua, H. (2026) · Journal of Functional Foods · doi:10.1016/j.jff.2026.107541
Wang, Q., Wang, S., Xu, Z., Song, L., Yang, K., Zhang, C., & Cheng, X. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27209364
Metadata
- Authors
- Puzzo, D., Gulisano, W., Palmeri, A., & Arancio, O.
- Affiliations
- University of Catania (IT)
- Columbia University (US)
- Venue
- Expert Opinion on Drug Discovery
- Publisher
- Informa UK Limited
- Published
- 2015-04-30
- Volume
- 10
- Issue
- 7
- Pages
- 703-711
- ISSN
- 1746-0441 (ISSN-L)
- 1746-045X
- PMC
- PMC4592281
- OpenAlex
- W1963514255
- Cited by
- 222
- References
- 91
- Citations by year
- 2026: 11 · 2025: 18 · 2024: 13 · 2023: 24 · 2022: 19 · 2021: 25 · 2020: 16 · 2019: 19 · 2018: 30 · 2017: 22 · 2016: 22 · 2015: 3
- FWCI
- 3.16
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Expert Opinion on Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Aging (R01AG034248, AG034248)
- National Institute of Neurological Disorders and Stroke (R01NS049442, NS49442)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, animal models, transgenic mice, APP/PS1 double transgenic mice, amyloid-beta, tau protein, amyloid plaques, neurofibrillary tangles, presenilin 1, amyloid precursor protein, physiological aging, drug discovery, preclinical testing
- MeSH terms
- Aging, Alzheimer Disease, Animals, Disease Models, Animal, Drug Evaluation, Preclinical, Humans, Mice, Transgenic, Rodentia, Species Specificity, Mice, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
